In this episode, we discuss how Cognaize is shaping the future of finance with their innovative AI solutions, analyzing the significance of their recent $18M funding raise and its impact on the industry.

In this episode, we delve into the unveiling of Meta's groundbreaking open innovation AI research community, discussing the controversies surrounding its launch and its implications for the global AI landscape.

In this episode, we uncover the remarkable capabilities of a scientific AI model that generates hypotheses about alien life and identifies the researchers most likely to make groundbreaking discoveries in the field.

In this episode, we dissect the latest Google Bard update, which enables users to code applications by simply uploading image screenshots, discussing its implications for streamlining development workflows and lowering barriers to entry in software engineering.

In this episode, we dissect the recent Hollywood strike protesting AI cloning of actors, examining the disruption it causes to the entertainment industry and the broader implications for technology's influence on creative expression.

In this episode, we dissect Meta's game-changing revelation of CM3leon AI, examining its advanced capabilities and the profound impact it may have on technological innovation.

In this episode, we delve into the implications of AI on customer service jobs, examining how the rise of AI-driven sales calls and chatbots is transforming the workforce and the customer service sector.

In this episode, we delve into Meta's strategic response to ChatGPT with the launch of a paid alternative, analyzing the implications for both companies and the future of AI-powered chatbots.

In this episode, we discuss the collaboration between Associated Press and OpenAI, raising questions about the evolving landscape of journalism and the implications of AI integration in news reporting.

In this episode, we delve into the transformative impact of Nvidia's $50M investment in Recursion, a pioneering AI-driven drug discovery firm, examining how this partnership could reshape the landscape of pharmaceutical research and development.